Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. - Wikidata - awgldk - TriplyDB

Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.

Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.

http://www.wikidata.org/entity/Q43757321

about

Infectious Complications after Umbilical Cord-Blood Transplantation from Unrelated Donors The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis.Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank.Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years.Concise review: umbilical cord blood transplantation: past, present, and future Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease Cord blood-derived hematopoietic stem/progenitor cells: current challenges in engraftment, infection, and ex vivo expansion.Immune Reactions following Cord Blood Transplantations in Adults.Allogeneic hematopoietic stem cell transplantation.Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results.Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries.Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.Umbilical cord blood grafts for hematopoietic transplantation in adults: a cup half empty or half full?The Role of HLA in Cord Blood Transplantation.Adult umbilical cord blood transplantation: a comprehensive review.Cord blood transplantation for adults.Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche.Expanding the role of umbilical cord blood transplantation.Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.Reduced-intensity conditioning and umbilical cord blood transplantation in adults.Cord blood transplantation in adults.History of cord blood transplantation.Cord Blood Transplantation: Can We Make it Better?The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression.Umbilical cord blood transplant for malignancies: a hope or hype.Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation.Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report.Results of the cord blood transplantation (COBLT) study unrelated donor banking program.Early infections in adult patients undergoing unrelated donor cord blood transplantation.Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH).Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time.Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes.Risk factors and options to improve engraftment in unrelated cord blood transplantation Allogeneic cord blood transplantation in children with hematological malignancies: a long-term follow-up single-center study.Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005.Unrelated cord blood transplantation after myeloablative conditioning in patients over the age of 45 years.

P2860

Q28066500-45B5BC51-3068-465A-AD4C-107D58DDE517 Q33445489-F32F6B79-B76C-41B6-B933-3E6888758AF6 Q33449843-5EC6EC55-E84F-4D9A-A242-17080D8C7905 Q33705051-DED9A2DA-C39F-47B1-A19A-7AB7551505F1 Q33816659-69D5BA0F-3E31-463B-A0C5-32EDBA1FA0E3 Q34470409-EDF293B9-A48C-4DC4-9CCC-2E6972B2997C Q34601968-3B0BC736-10F9-4DE9-9CE3-0AFE8B3EDA38 Q34985679-F4A569D8-51A2-40A5-9743-D273E9E7EEE3 Q34986499-BE30C369-7879-41B5-B7C1-036CFA1D7E2F Q35054475-81572B31-B2E0-43F3-9129-44EEB787D9FB Q35201902-2CE3D0B7-1E2D-4A77-B455-EB5017DEEE9B Q35674530-D24D39B3-D54E-4F3C-B814-7150DC976D4C Q35850703-5721F2E6-53AB-4630-A70E-347405CAEBDD Q36004664-3FD30352-9795-465F-9ED4-509C8F0FB550 Q36059652-F1E825DE-55D6-4664-8455-A6416F34D3D4 Q36150943-AAC0906C-E6EF-4A37-B7D2-F6852AF9ADA1 Q36336608-E82A63E4-F41B-4FDA-A069-2AAA92F86399 Q36496725-21F84720-9CD3-4603-BAFF-BA846FA302EE Q36588337-E7A7429D-B37D-40DD-9D55-63E392EB0B90 Q36681962-66E0CD34-C036-4D2D-AC1C-6A921E25F64B Q36759585-210A1390-916E-49F6-9E1A-163CA324C506 Q37207777-35462A1D-5010-4609-B2DD-3CCAA4F1B9D3 Q37607984-9ABFE7B8-6CBC-496B-A540-33B1A8918B58 Q37607986-CB30ECE7-F5A6-4C56-AADB-971EF51BB692 Q37607988-8FDDE7F8-A1F8-4271-AC45-C91213838B0A Q38142167-4C6D9E33-289E-48FF-942A-71808EE25E61 Q38163428-548B1E78-A90E-4571-91DB-92E7B63BBA20 Q39421621-77DE5246-C9C0-43C2-BA45-8C133E3DA54B Q40311559-C3FD0769-6BC5-457E-BB47-5C2D77F91FEA Q40351661-6AE70B63-548F-49E5-99E1-2F11C534FAA1 Q40416657-3278B908-10D6-4663-9562-7198CE4A0490 Q40416663-B7E4D8C0-D9CF-4938-8F22-19569173D9FC Q40569370-FCBB8943-F1F4-41B8-80DB-D31211DD8B45 Q41478754-FF9B6E8D-F4C9-4593-82F5-251545E3A406 Q41688144-674BF8DD-8552-44CA-9AFB-F003B46D4A16 Q41877676-DDF7D9E3-B969-4415-ACDB-885C27333B6F Q42735351-5D94D786-F914-4B78-9521-8DBC19DAA8A8 Q43602281-6689D32F-A6CF-415E-B8C7-3D7A16191BEB Q43730176-BDEEC124-6545-45DB-BAF2-B7BE987697BC Q44718475-DB2A1F9B-1030-4A0E-B61C-6F8B66D598A0

P2860

Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.

http://www.wikidata.org/entity/Q43757321

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Standardized, unrelated donor ...... with hematologic malignancies.

@en

Standardized, unrelated donor ...... with hematologic malignancies.

@nl

type

label

Standardized, unrelated donor ...... with hematologic malignancies.

@en

Standardized, unrelated donor ...... with hematologic malignancies.

@nl

prefLabel

Standardized, unrelated donor ...... with hematologic malignancies.

@en

Standardized, unrelated donor ...... with hematologic malignancies.

@nl

P1433

Q43757321-1DE19995-0A73-4DE0-9BA9-F341DD1B4EBC

P1476

Q43757321-14130628-C1DF-4B6C-8B0F-A0C539EF5CCB

P2093

Q43757321-0189CCD5-9E9F-4945-A5FA-8876362F6185

Q43757321-02AB3A5F-6105-4078-9E72-139BC928F7C1

Q43757321-105CE853-B0C1-4317-99AD-7FDC77884BE7

Q43757321-2070A72A-D043-4A7A-9A6A-372F6A9D92C8

Q43757321-33B06CA0-2B27-487F-8C3A-9C0D6184AB3D

Q43757321-33FE0B24-F330-4885-95C0-A7678F0CAC34

Q43757321-43BBFA90-140D-4274-BC7E-6253B73D9723

Q43757321-4A4FB8F9-62E8-4C73-A98D-DEA8D763C407

Q43757321-4C358128-D735-456C-9B78-7D4E24A7396E

Q43757321-5942DA8D-629B-4A2F-AAEF-3E7D8505393C

P304

Q43757321-141F15B4-FCFF-45A1-8AB1-224E049C834E

P31

Q43757321-98BC8E2E-2F14-4639-9D07-13CA1EEE0576

P356

Q43757321-3A70D48A-1A3E-4465-9DFF-2479531BDCB7

P407

Q43757321-52A97D52-04FC-4E36-96C3-F4446D59F994

P433

Q43757321-B773AA97-C9CA-4E73-8E04-EC65BCA621D1

P478

Q43757321-10D9A212-0756-4E32-B480-E6B931EBEABE

P577

Q43757321-15E4E25F-00C7-478F-A9B8-FC5033E8CA1F

P698

Q43757321-8DF88659-A7F7-4A8B-998F-92096E848F73

P356

BLOOD.V98.8.2332

P1433

P1476

Standardized, unrelated donor ...... with hematologic malignancies.

@en

P2093

Andreu R

http://www.w3.org/2001/XMLSchema#string

Barragán E

http://www.w3.org/2001/XMLSchema#string

Benlloch L

http://www.w3.org/2001/XMLSchema#string

Bolufer P

http://www.w3.org/2001/XMLSchema#string

Cervera J

http://www.w3.org/2001/XMLSchema#string

García I

http://www.w3.org/2001/XMLSchema#string

Jarque I

http://www.w3.org/2001/XMLSchema#string

Jiménez C

http://www.w3.org/2001/XMLSchema#string

Larrea L

http://www.w3.org/2001/XMLSchema#string

Marty ML

http://www.w3.org/2001/XMLSchema#string

P304

2332-2338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD.V98.8.2332

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11588027

http://www.w3.org/2001/XMLSchema#string